Drugs Made In America Acquisition II Corp. (DMIIU) Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Current Assets of $26037.0 for Q4 2025, down 56.32% year-over-year from $59615.0 in Q4 2024, and down 97.1% quarter-over-quarter from $896356.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Current Assets for 2 consecutive years, with $26037.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 56.32% year-over-year to $26037.0; the TTM figure through Dec 2025 stood at $26037.0 (down 56.32% YoY), while the FY2025 annual figure was $26037.0, down 56.32% from the prior year.
- Current Assets retreated to $26037.0 in Q4 2025 per DMIIU's latest filing, from $896356.0 in the prior quarter.
- Across five years, Current Assets topped out at $896356.0 in Q3 2025 and bottomed at $26037.0 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,037.00 |
| Sep 30, 2025 | 896,356.00 |
| Dec 31, 2024 | 59,615.00 |